Aura Biosciences, Inc.
HealthcareNASDAQ:AURA · NASDAQ Global Market
+$0.20 today
Vol 0.96M · Avg 0.50M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-0.16%
Period High
$8.90
Period Low
$4.97
Latest
$6.41
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$814.99M
Design Therapeutics, Inc.
NASDAQ:DSGN
$685.15M
Annexon, Inc.
NASDAQ:ANNX
$563.29M
Solid Biosciences Inc.
NASDAQ:SLDB
$556.28M
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$300.28M
Altimmune, Inc.
NASDAQ:ALT
$230.35M
Quantum-Si incorporated
NASDAQ:QSI
$187.28M
Korro Bio, Inc.
NASDAQ:KRRO
$115.56M
enGene Holdings Inc.
NASDAQ:ENGN
$82.94M
What is the latest AURA filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does AURA have?
Intrinsic Alpha currently shows 20 recent filings for AURA.
Explore More
Continue the stock analysis
Jump to another research area for this company.